'Good news,' says doctor: Some Quebec COVID-19 patients to soon have access to monoclonal antibody treatment
Quebec is preparing to accept delivery of a small but potentially lifesaving shipment of a COVID-19 antibody treatment, which some doctors say will be a great added disease-fighting tool - if the province’s health authorities can organize the resources needed to drip it into patients’ arms.
The limited supply of the monoclonal antibody cocktail is being divvied up amongst the provinces by Canada’s Public Health Agency.
Quebec is to receive only “a few hundred doses,” according to a health ministry directive issued on Oct. 8.
"It’s a very important treatment for a special population of people who are vulnerable to severe complications," said Dr. Emily McDonald, a scientist in the infectious disease and immunity in global health program at the RI-MUHC.
These particular COVID-19 patients "may have done their best to protect themselves from seeking out the vaccine but weren't able to respond to it," said McDonald, who is also an internal medicine doctor.
Getting fully vaccinated remains the best and least costly avenue to prevent severe disease and hospitalization.
But for those who need them, the monoclonal antibodies, part of a class of medications, mimic the immune system’s ability to fight off the virus.
Quebec will be receiving a new combination of the antibodies: Casirivimab and Imdevimab.
According to INESSS, “if the drugs are used in a very targeted and timely way, they could help prevent hospitalizations."
WHO’S ELIGIBLE FOR TREATMENT?
The monoclonal antibodies are ideal for patients who are inadequately protected either because they have a medical condition that has compromised their immune systems, had organ transplants, chemotherapy treatment, or suffer from an autoimmune disease like rheumatoid arthritis, for example.
It is most effective when administered within seven days after a positive COVID-19 test.
Efficacy depends on several factors but in ideal circumstances, McDonald said "there are some studies that show that if you treat five people you might prevent one hospitalization, so pretty effective."
Late last month the World Health Organization backed the use of the antibodies in select, high-risk patients.
In light of the fourth wave and the current fragility of the health care network, Quebec's health ministry has asked health authorities to establish at least one site in a facility on their territory where the treatment can be administered.
It’s not a simple request, given that it involves bringing an outpatient who has COVID-19 into a hospital or clinic with all the risks and complications that entails.
And they’ll have to allocate the appropriate health care worker to the task, since the treatment itself is not a basic injection, but rather, involves an hour-long intravenous infusion.
WHAT TOOK SO LONG?
Monoclonal antibodies have been used extensively to treat COVID-19 in the United States for some time, so why haven’t Quebecers benefitted yet?
It seems that at least a couple of problems stood in the way- one biological and one logistical.
While a single monoclonal antibody, Bamlanivimab, was authorized by Health Canada in 2020, the treatment didn’t get a “positive enough recommendation” from scientists at Quebec’s institute for excellence in health (INESSS),” according to the health ministry and wasn’t rolled out extensively.
And then, whatever limited usefulness it had diminished over time as the virus continued to spread around the world, and changed.
“We found that that [with] the single monoclonal antibody...some of the variants were developing a resistance to it,” McDonald said.
There was also the previously mentioned issue around identifying a treatment site for outpatients and finding nurses who would be able to work there when needed.
But though there's limited data out the new combo-drug is performing better and will soon be accessible in the province - albeit in very limited supply.
“There remains this population of people who will never respond to the vaccine or respond poorly and it's I think it's really incredible that we have this treatment to offer them,” said McDonald.
CTVNews.ca Top Stories
From outer space? Sask. farmers baffled after discovering strange wreckage in field
A family of fifth generation farmers from Ituna, Sask. are trying to find answers after discovering several strange objects lying on their land.
Broadcaster and commentator Rex Murphy dead at 77: National Post
The National Post is reporting that Rex Murphy, the pundit and columnist who hosted a national call-in radio show for decades, has died.
Pearson gold heist suspect arrested after flying into Toronto from India
Another suspect is in custody in connection with the gold heist at Toronto Pearson International Airport last year, police say.
Millions of cyberattacks per hour as B.C. government investigates multiple breaches
Careful attention to government statements and legislation is required to get a handle on the level of risk British Columbians’ information is under, as investigators probe multiple breaches under a continued barrage of attacks.
Ontario family receives massive hospital bill as part of LTC law, refuses to pay
A southwestern Ontario woman has received an $8,400 bill from a hospital in Windsor, Ont., after she refused to put her mother in a nursing home she hated -- and she says she has no intention of paying it.
Debate on abortion rights erupts on Parliament Hill, Poilievre vows he won't legislate
A Conservative government led by Pierre Poilievre would not legislate on, nor use the notwithstanding clause, on abortion, his office says, as anti-abortion protesters gather on Parliament Hill.
Justin and Hailey Bieber are expecting their first child together
Hailey and Justin Bieber are going to be parents. The couple announced the news on Thursday on Instagram, both sharing a video that showcases Hailey Bieber's growing belly.
Here are the ultraprocessed foods you most need to avoid, according to a 30-year study
Studies have shown that ultraprocessed foods can have a detrimental impact on health. But 30 years of research show they don’t all have the same impact.
New 'Lord of the Rings' film coming in 2026
The Oscar-winning team behind the nearly US$6 billion blockbuster 'Lord of the Rings' and 'The Hobbit' trilogies is reuniting to produce two new films.